You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

sema4a

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Inflammatory Disease in Multiple Sclerosis

Active, not recruiting
  • Relapsing Multiple Sclerosis
  • Multiple Sclerosis
  • Cerebrospinal and Blood Serum Semaphorin 4A Levels
  • Portland, Oregon
    Providence St. Vincent Medical Center
May 19, 2022

Avera/Sema4 Oncology and Analytics Protocol

Recruiting
  • Cancer
  • +11 more
    • Sioux Falls, South Dakota
      Avera Cancer Institute
    Jan 30, 2023

    SEMA4C as a Relapse Biomarker in Breast Cancer

    Not yet recruiting
    • Breast Cancer
    • SEMA4C high value follow-up group
    • SEMA4C low value follow-up group
    • (no location specified)
    Oct 6, 2021

    Diagnosis Value of SEMA4C in Breast Cancer

    Not yet recruiting
    • Breast Neoplasm Female
    • Breast cancer group
    • Benign breast tumor group
    • (no location specified)
    Oct 18, 2022

    Pregnancy Related, Pregnancy Early, Wearables Trial in Seattle

    Recruiting
    • Pregnancy Related
    • +2 more
      • Seattle, Washington
        4YouandMe
      Mar 9, 2022

      Cardiomyopathy, Heart Failure With Preserved Ejection Fraction (HFpEF), Obesity Trial in Rochester (Semaglutide, Placebo,

      Recruiting
      • Cardiomyopathy
      • +2 more
      • Rochester, Minnesota
        Mayo Clinic in Rochester
      Jan 3, 2023

      Relaxin in Multiple Sclerosis (MS)

      Recruiting
      • Multiple Sclerosis, Relapsing-Remitting
      • Blood Draw
      • Lumbar Puncture
      • Portland, Oregon
        Providence MS Center
      Feb 2, 2022

      Diabetes, Type 2 Trial in Neuss (NNC0148-0287sema, Semaglutide, NNC0148-0287)

      Completed
      • Diabetes Mellitus, Type 2
      • Neuss, Germany
        Novo Nordisk Investigational Site
      Sep 28, 2021

      Oral Health and Life Quality of Molar Incisor Hypomineralization

      Completed
      • Molar Incisor Hypomineralization
      • +6 more
      • survey application
      • Rize, Turkey
        Sema Aydinoğlu
      Mar 9, 2023

      Squamous Cell Carcinoma of the Head and Neck Trial in Atlanta (VX15/2503, Ipilimumab, Nivolumab)

      Recruiting
      • Squamous Cell Carcinoma of the Head and Neck
      • VX15/2503
      • +2 more
      • Atlanta, Georgia
        Emory University Hospital Midtown
      Mar 2, 2022

      Metastatic Melanoma, Stage III Cutaneous Melanoma AJCC v7, Stage IIIA Cutaneous Melanoma AJCC v7 Trial in Los Angeles, Salt Lake

      Terminated
      • Metastatic Melanoma
      • +5 more
      • Anti-SEMA4D Monoclonal Antibody VX15/2503
      • +4 more
      • Los Angeles, California
      • +1 more
      Apr 1, 2021

      Sandplay Therapy, Anxiety Trial in Isparta (Sandplay activity, Routine Care)

      Completed
      • Sandplay Therapy
      • Anxiety
      • Sandplay activity
      • Routine Care
      • Isparta, Merkez, Turkey
        Sema Soysal
      Sep 29, 2021

      O-SEMA-Fast: A Research Study to Understand How Oral Semaglutide

      Not yet recruiting
      • Diabetes Mellitus, Type 2
      • Ahmadi, Kuwait
      • +16 more
      Jan 29, 2023

      Nonalcoholic Steatohepatitis Trial in Worldwide (Semaglutide (SEMA), Cilofexor (CILO)/Firsocostat (FIR), PTM SEMA)

      Recruiting
      • Nonalcoholic Steatohepatitis
      • Semaglutide (SEMA)
      • +3 more
      • Birmingham, Alabama
      • +149 more
      Jul 28, 2022

      Colon Carcinoma Metastatic in the Liver, Colorectal Adenocarcinoma, Pancreatic Adenocarcinoma Trial in Atlanta, Rochester

      Active, not recruiting
      • Colon Carcinoma Metastatic in the Liver
      • +13 more
      • Anti-SEMA4D Monoclonal Antibody VX15/2503
      • +3 more
      • Atlanta, Georgia
      • +3 more
      Dec 15, 2021

      Keloid, Wound Heal, Wound Trial in Singapore (siSPARC + siLR4A microneedle patches, siSPARC microneedle patch)

      Recruiting
      • Keloid
      • +2 more
      • siSPARC + siLR4A microneedle patches
      • siSPARC microneedle patch
      • Singapore, Singapore
        National Skin Centre
      Nov 17, 2023

      Epidemic Meningitis Trial (MCV4, MSPV4)

      Not yet recruiting
      • Epidemic Meningitis
      • MCV4
      • MSPV4
      • (no location specified)
      Aug 21, 2023

      Behçet's Disease Trial in Beijing (Hemay005, Placebo)

      Recruiting
      • Behçet's Disease
      • Beijing, Beijing, China
        Peking University People's Hospital
      Nov 17, 2023

      Obesity Trial in Berlin (Semaglutide D Dose 1, Semaglutide D Dose 2, Semaglutide D Dose 3)

      Completed
      • Obesity
      • Semaglutide D Dose 1
      • +6 more
      • Berlin, Germany
        Novo Nordisk Investigational Site
      Dec 12, 2022

      Healthy Trial in London (NTP42:KVA4 Capsule, NTP42:KVA4 Liquid)

      Recruiting
      • Healthy
      • NTP42:KVA4 Capsule
      • NTP42:KVA4 Liquid
      • London, United Kingdom
        Hammersmith Medicines Research
      Oct 20, 2023

      Mental Health Issue, Mental Health Wellness 1 Trial in London (MeT4VeT mobile phone app: control, MeT4VeT mobile phone app:

      Completed
      • Mental Health Issue
      • Mental Health Wellness 1
      • MeT4VeT mobile phone app: control
      • MeT4VeT mobile phone app: intervention
      • London, United Kingdom
        King's College London
      Aug 8, 2023

      Sensorineural Hearing Loss, Bilateral, Bilateral Hearing Loss Trial in Saint-Étienne (FS4 then TFS4 (cochlear implant), TFS4

      Not yet recruiting
      • Sensorineural Hearing Loss, Bilateral
      • Bilateral Hearing Loss
      • FS4 then TFS4 (cochlear implant)
      • TFS4 then FS4 (cochlear implant)
      • Saint-Étienne, France
        CHU Saint-Etienne
      Jul 13, 2023

      Pregnancy Related, Adolescent Behavior, Sexually Transmitted Diseases Trial in Berkeley (Next4You)

      Enrolling by invitation
      • Pregnancy Related
      • +2 more
      • Next4You
      • Berkeley, California
        RTI
      Nov 7, 2023

      Bladder Cancer Trial (Multi4)

      Not yet recruiting
      • Bladder Cancer
      • Multi4
      • (no location specified)
      Nov 14, 2023

      Diabetes Type 2 With Proteinuria, Diabetes, Type 2, Diabetes Trial (drug, device, diagnostic test, behavioral)

      Not yet recruiting
      • Diabetes Mellitus Type 2 With Proteinuria
      • +12 more
      • Empagliflozin 10 MG
      • +6 more
      • (no location specified)
      Oct 17, 2023